Genmab As Stock Filter Stocks by Fundamentals
GMAB Stock | DKK 1,994 12.50 0.62% |
Genmab AS fundamentals help investors to digest information that contributes to Genmab AS's financial success or failures. It also enables traders to predict the movement of Genmab Stock. The fundamental analysis module provides a way to measure Genmab AS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genmab AS stock.
Genmab |
Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
All Next | Launch Module |
Genmab Fundamentals
Return On Equity | 0.24 | |||
Return On Asset | 0.1 | |||
Profit Margin | 0.47 % | |||
Operating Margin | 0.38 % | |||
Current Valuation | 186.33 B | |||
Shares Outstanding | 65.96 M | |||
Shares Owned By Institutions | 49.90 % | |||
Price To Earning | 34.78 X | |||
Price To Book | 7.86 X | |||
Price To Sales | 17.00 X | |||
Revenue | 8.48 B | |||
Gross Profit | 8.48 B | |||
EBITDA | 4.24 B | |||
Net Income | 3.01 B | |||
Cash And Equivalents | 18.08 B | |||
Cash Per Share | 276.57 X | |||
Total Debt | 378 M | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 15.42 X | |||
Book Value Per Share | 408.67 X | |||
Cash Flow From Operations | 2.23 B | |||
Earnings Per Share | 83.21 X | |||
Price To Earnings To Growth | 1.19 X | |||
Target Price | 3239.73 | |||
Number Of Employees | 1.56 K | |||
Beta | 0.67 | |||
Market Capitalization | 185.21 B | |||
Total Asset | 24.63 B | |||
Net Asset | 24.63 B |
About Genmab AS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genmab AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genmab AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genmab AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Genmab Stock analysis
When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |